HomeDMYD-B • STO
add
Diamyd Medical AB
Nakaraang pagsara
kr 17.30
Sakop ng araw
kr 16.68 - kr 17.88
Sakop ng taon
kr 7.50 - kr 17.88
Market cap
2.36B SEK
Average na Volume
598.91K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Bloomberg.com
41 minuto ang nakalipas
Asian Stocks Pare Losses After US Tech-Led Selloff: Markets Wrap
0.84%
0.34%
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Nob 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 245.00K | 842.31% |
Gastos sa pagpapatakbo | 48.14M | 15.02% |
Net na kita | -48.84M | -35.07% |
Net profit margin | -19.94K | 85.67% |
Kita sa bawat share | — | — |
EBITDA | -47.06M | -13.67% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Nob 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 233.18M | 52.53% |
Kabuuang asset | 302.46M | 35.70% |
Kabuuang sagutin | 70.82M | 6.05% |
Kabuuang equity | 231.64M | — |
Natitirang share | 137.50M | — |
Presyo para makapag-book | 10.30 | — |
Return on assets | -37.27% | — |
Return on capital | -47.73% | — |
Cash Flow
Net change in cash
| (SEK) | Nob 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -48.84M | -35.07% |
Cash mula sa mga operasyon | -43.70M | -4.49% |
Cash mula sa pag-invest | -20.10M | -183.55% |
Cash mula sa financing | 7.00K | -99.99% |
Net change in cash | -63.85M | -259.15% |
Malayang cash flow | -27.48M | 11.67% |
Tungkol
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Itinatag
1984
Website
Mga Empleyado
41
